{"denoms":[{"counts":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"15"},{"groupId":"BG005","value":"21"},{"groupId":"BG006","value":"69"}],"units":"Participants"}],"groups":[{"description":"Participants received 1 mg/kg E-602 monotherapy administered weekly via IV infusion.","id":"BG000","title":"E-602 1 mg/kg"},{"description":"Participants received 3 mg/kg E-602 monotherapy administered weekly via IV infusion.","id":"BG001","title":"E-602 3 mg/kg"},{"description":"Participants received 10 mg/kg E-602 monotherapy administered weekly via IV infusion.","id":"BG002","title":"E-602 10 mg/kg"},{"description":"Participants received 20 mg/kg E-602 monotherapy administered weekly via IV infusion.","id":"BG003","title":"E-602 20 mg/kg"},{"description":"Participants received 30 mg/kg E-602 monotherapy administered weekly via IV infusion.","id":"BG004","title":"E-602 30 mg/kg"},{"description":"Participants received 20 mg/kg E-602 monotherapy administered weekly via IV infusion. They also received 350 mg cemiplimab administered every 3 weeks via IV infusion.","id":"BG005","title":"E-602 20 mg/kg in Combination With Cemiplimab"},{"description":"Total of all reporting groups","id":"BG006","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.79","value":"57.0"},{"groupId":"BG001","spread":"11.17","value":"60.0"},{"groupId":"BG002","spread":"12.39","value":"57.9"},{"groupId":"BG003","spread":"9.36","value":"59.1"},{"groupId":"BG004","spread":"10.25","value":"62.1"},{"groupId":"BG005","spread":"10.31","value":"66.5"},{"groupId":"BG006","spread":"10.67","value":"61.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"7"},{"groupId":"BG005","value":"11"},{"groupId":"BG006","value":"36"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"8"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"10"},{"groupId":"BG006","value":"33"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"2"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"5"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"3"}]}],"title":"Black or African American"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"13"},{"groupId":"BG005","value":"18"},{"groupId":"BG006","value":"56"}]}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"2"}]}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"3"}]}],"title":"Not Reported"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"Safety population was used for analysis purposes."}